AMITIZA & IBS with Constipation
It's very important for you to describe your symptoms to your healthcare provider, especially what you feel. By understanding the symptoms of Irritable Bowel Syndrome with Constipation (IBS-C), you can help your healthcare provider recognize your condition and develop an appropriate treatment plan for you.
Recognize these symptoms of IBS:
- Abdominal pain or discomfort for at least 6 months
Plus 2 or more of these:
- Relief with a bowel movement
- Changes in the number of bowel movements per week
- Stool appearance changes
If you have IBS-C, your symptoms may also include 2 or more of these:
- Fewer than 3 bowel movements a week
- Hard stool at least 25% of the time
- 25% or more of your bowel movements involve straining
Once your healthcare provider has a clear understanding of your symptoms, you can get an appropriate treatment. Ask your healthcare provider if AMITIZA may be right for you.
Fill in this Symptom Tracker for 3 weeks and take it to your healthcare provider to help them find out if your bowel problems may be IBS-C.
AMITIZA Is Approved to Treat IBS-C in Adult Women
AMITIZA (8 mcg) twice daily is the only FDA-approved prescription treatment for IBS-C in women 18 years of age and older.
Remember, combining a healthy diet with regular exercise and reduced stress levels is a good place to start. However, if you're still suffering from IBS-C, it may be time to try prescription AMITIZA. The most important thing is to talk to your doctor, and then ask about AMITIZA.
Indication
AMITIZA (8 mcg) twice daily is approved to treat Irritable Bowel Syndrome with Constipation (IBS-C) in women 18 years of age and older.
Important Safety Information
AMITIZA is not for everyone. If you know or suspect you have a bowel blockage, do not take AMITIZA. If you are unsure, your healthcare provider should evaluate your condition before starting AMITIZA. You should not take AMITIZA if you have severe diarrhea.
AMITIZA has not been studied in pregnant women and should only be used during a pregnancy if the potential benefits justify the potential risk to the fetus. Women should have a negative pregnancy test before beginning treatment with AMITIZA and need to practice effective birth control measures. If you are pregnant or become pregnant while being treated with AMITIZA, talk to your healthcare provider to evaluate the risks to the fetus.
Some patients taking AMITIZA may experience nausea or diarrhea. If nausea occurs, take AMITIZA with food. If your nausea or diarrhea becomes severe, tell your healthcare provider.
Within an hour of taking AMITIZA, a sensation of chest tightness and shortness of breath may occur. These symptoms usually go away within three hours, but may recur with repeated use. Tell your healthcare provider if you experience these symptoms.
The most common side effects of taking AMITIZA (8 mcg) twice daily, pink capsules for IBS-C are nausea, diarrhea, and abdominal pain. These are not all the side effects associated with AMITIZA.
Tell your doctor if you have liver problems.
Please click here for complete Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
